CLINICAL NUCLEAR MEDICINE, cilt.50, sa.7, 2025 (SCI-Expanded)
Ga-68-FAPI has emerged as an alternative tracer for tumor imaging, as FAP is expressed in >90% of epithelial cancers. Although promising data on this new radiotracer are increasing, false-positive results due to nonmalignant diseases with FAP uptake are also reported (for instance, chronic inflammation, arthritis, and fibrosis). In this case, we demonstrated Ga-68-FAPI PET/CT involvement in a patient diagnosed with hepatic sarcoidosis.